Table 3.
Estimates of unadjusted and adjusted treatment effect at each time point.
| Unadjusted |
Adjusted |
|||||||
|---|---|---|---|---|---|---|---|---|
| Estimate (SE) | 95% CI | P value | Standardised treatment effecta | Estimate (SE) | 95% CI | P value | Standardised treatment effect | |
| CORE-OM mean | ||||||||
| 4 months | − 0.135 (0.102) | − 0.337 to 0.067 | 0.188 | − 0.198 | − 0.157 (0.099) | − 0.353 to 0.039 | 0.114 | − 0.231 |
| 10 months | − 0.108 (0.134) | − 0.373 to 0.158 | 0.423 | − 0.158 | − 0.154 (0.131) | − 0.416 to 0.107 | 0.243 | − 0.227 |
| HADS anxiety total | ||||||||
| 4 months | − 0.648 (0.705) | − 2.049 to 0.754 | 0.361 | − 0.177 | − 0.649 (0.674) | − 1.989 to 0.69 | 0.338 | − 0.178 |
| 10 months | − 0.865 (0.874) | − 2.605 to 0.875 | 0.325 | − 0.236 | − 0.726 (0.809) | − 2.339 to 0.886 | 0.372 | − 0.199 |
| HADS depression total | ||||||||
| 4 months | − 1.743 (0.712) | − 3.157 to − 0.328 | 0.016 | − 0.373 | − 1.67 (0.719) | − 3.1 to − 0.241 | 0.023 | − 0.358 |
| 10 months | − 1.489 (0.74) | − 2.962 to − 0.016 | 0.048 | − 0.319 | − 1.456 (0.685) | − 2.821 to − 0.092 | 0.037 | − 0.312 |
| Choice severity mean | ||||||||
| 4 months | 0.653 (0.298) | 0.06 to 1.245 | 0.031 | 0.367 | 0.581 (0.3) | − 0.015 to 1.177 | 0.056 | 0.327 |
| 10 months | 0.401 (0.318) | − 0.233 to 1.035 | 0.212 | 0.225 | 0.35 (0.319) | − 0.286 to 0.986 | 0.277 | 0.197 |
| Choice satisfaction mean | ||||||||
| 4 months | 0.881 (0.383) | 0.119 to 1.643 | 0.024 | 0.422 | 0.879 (0.372) | 0.141 to 1.618 | 0.020 | 0.421 |
| 10 months | 0.363 (0.433) | − 0.499 to 1.226 | 0.404 | 0.174 | 0.387 (0.416) | − 0.442 to 1.216 | 0.356 | 0.185 |
| PSYRATS total | ||||||||
| 4 months | − 1.198 (1.509) | − 4.196 to 1.801 | 0.430 | − 0.189 | − 1.273 (1.488) | − 4.23 to 1.685 | 0.395 | − 0.201 |
| 10 months | 2.331 (2.007) | − 1.667 to 6.329 | 0.249 | 0.367 | 2.449 (2.082) | − 1.696 to 6.595 | 0.243 | 0.386 |
CORE-OM = clinical outcomes in routine evaluation; HADS = Hospital Anxiety & Depression Scale; PSYRATS = psychotic symptom rating scales; CHOICE = self-report assessment of recovery.
Treatment effect divided by the baseline variance.